Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Recommendation of "Hold" by Brokerages

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has received a consensus "Hold" rating from 22 brokerages, with an average 12-month price target of $103.00. The company recently exceeded quarterly expectations, reporting $2.07 in adjusted EPS and $2.18 billion in revenue, and has declared a quarterly dividend of $0.24 per share. Insider transactions show recent sales by Kevin R. Thornal and Chad F. Phipps, while institutional investors own a significant 88.89% of the stock.